There are currently no events to display.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain.
ACRX (Common Stock)
Data provided by Nasdaq. Minimum 15 minutes delayed.
09/06/17Sep062017 Summary ToggleAcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in September
08/01/17Aug012017 Summary ToggleAcelRx Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
08/01/17Aug012017 Summary ToggleAcelRx Pharmaceuticals Reports Successful Outcome of ZALVISO Phase 3 IAP312 Study on Device Functionality
September 2017 Corporate Presentation